TM

Taher Mufaddalbhai Sathaliya

Active Director Director DIN 07615480
DIN 07615480 First appointment Oct 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Taher Mufaddalbhai Sathaliya

Data last updated:

Taher Mufaddalbhai Sathaliya is a Director at Imod Therapeutics Private Limited (since 2016). The company operates in Business Services.

DIN 07615480
Primary Designation Director
Industry Business Services
First Appointment 06 Oct 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Imod Therapeutics Private Limited U74999GJ2016PTC094017
Director06 Oct 20162016Active

Board colleagues of Taher Mufaddalbhai Sathaliya

Directorship timeline

Open interactive timeline →
Imod Therapeutics Private Limited
Premium access

Shareholding and investment profile for Taher Mufaddalbhai Sathaliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Taher Mufaddalbhai Sathaliya

Taher Mufaddalbhai Sathaliya currently holds 1 directorship: Imod Therapeutics Private Limited (Director, since 06 Oct 2016).

Taher Mufaddalbhai Sathaliya was first appointed on 06 Oct 2016 as Director at Imod Therapeutics Private Limited.

The current boards of Taher Mufaddalbhai Sathaliya's companies include Khujembhai Fakhruddinbhai Jharanwala (Imod Therapeutics Private Limited), Yusufi Fakhruddinbhai Limdiiwala (Imod Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available